Literature DB >> 12230943

Triptolide inhibits proinflammatory factor-induced over-expression of class II MHC and B7 molecules in renal tubular epithelial cells.

Heng Li1, Zhi-Hong Liu, Chun-Sun Dai, Dong Liu, Lei-Shi Li.   

Abstract

AIM: To investigate the effects of triptolide on proinflammatory factor-induced over-expression of class II major histocompatibility complex (class II MHC), B7-1, B7-2, and intercellular adhesion molecule-1 (ICAM-1) in human proximal tubular epithelial (HKC) cells.
METHODS: HKC cells were exposed to both interferon gamma (IFN-gamma, 200 microg/L) and tumor necrosis factor alpha (TNF-alpha, 20 microg/L) and cultured in media containing different concentrations of triptolide for 24 h. Class II MHC, B7-1, B7-2, and ICAM-1 levels in HKC cells were evaluated by flow cytometry. ICAM-1 mRNA level was measured by semi-quantitative RT-PCR method.
RESULTS: HKC cells expressed quite high level of ICAM-1 and very low levels of class II MHC, B7-1, and B7-2 molecules. Class II MHC, B7-1, B7-2, and ICAM-1 levels in HKC cells were significantly increased by the costimulation of IFN-gamma and TNF-alpha. Triptolide inhibited the over-expression of class II MHC, B7-1, and B7-2 molecules in a concentration-dependent manner. The up-regulations of ICAM-1 molecules and ICAM-1 mRNA level were not altered by triptolide.
CONCLUSION: Triptolide can significantly inhibit proinflammatory factors induced over-expression of class II MHC, B7-1, and B7-2 costimulatory factors in tubular epithelial cells. These results may contribute to the therapeutic effects of triptolide in some renal diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230943

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  3 in total

Review 1.  Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects.

Authors:  Cong-Ying Song; Ying-Ge Xu; Yuan-Qiang Lu
Journal:  J Zhejiang Univ Sci B       Date:  2020 Apr.       Impact factor: 3.066

Review 2.  New Therapeutic Horizon of Graves' Hyperthyroidism: Treatment Regimens Based on Immunology and Ingredients From Traditional Chinese Medicine.

Authors:  Qiongyao He; Hui Dong; Minmin Gong; Yujin Guo; Qingsong Xia; Jing Gong; Fuer Lu
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

3.  Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study.

Authors:  Shanshan Liu; Xiayu Li; Heng Li; Qian Liang; Jun Chen; Jianghua Chen
Journal:  BMC Nephrol       Date:  2015-12-04       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.